|
1
|
Coffin CM, Dehner LP and Meis-Kindblom JM:
Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma and
related lesions: An historical review with differential diagnostic
considerations. Semin Diagn Pathol. 15:102–110. 1998.PubMed/NCBI
|
|
2
|
Pungpapong S, Geiger XJ and Raimondo M:
Inflammatory myofibroblastic tumor presenting as a pancreatic mass:
A case report and review of the literature. JOP. 5:360–367.
2004.PubMed/NCBI
|
|
3
|
Yamamoto H, Watanabe K, Nagata M, Tasaki
K, Honda I, Watanabe S, Soda H and Takenouti T: Inflammatory
myofibroblastic tumor (IMT) of the pancreas. J Hepatobiliary
Pancreat Surg. 9:116–119. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Coffin CM, Watterson J, Priest JR and
Dehner LP: Extrapulmonary inflammatory myofibroblastic tumor
(inflammatory pseudotumor). A clinicopathologic and
immunohistochemical study of 84 cases. Am J Surg Pathol.
19:859–872. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ziadi S, Trimeche M, Mestiri S, Boujelbene
N, Mokni M, Sriha B and Korbi S: Retroperitoneal myofibroblastic
inflammatory tumor. Tunis Med. 89:400–401. 2011.PubMed/NCBI
|
|
6
|
Coffin CM, Hornick JL and Fletcher CD:
Inflammatory myofibroblastic tumor: Comparison of
clinicopathologic, histologic, and immunohistochemical features
including ALK expression in atypical and aggressive cases. Am J
Surg Pathol. 31:509–520. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bertocchini A, Lo Zupone C, Callea F,
Gennari F, Serra A, Monti L, de Ville de and Goyet J: Unresectable
multifocal omental and peritoneal inflammatory myofibroblastic
tumor in a child: Revisiting the role of adjuvant therapy. J
Pediatr Surg. 46:e17–e21. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Griffin CA, Hawkins AL, Dvorak C, Henkle
C, Ellingham T and Perlman EJ: Recurrent involvement of 2p23 in
inflammatory myofibroblastic tumors. Cancer Res. 59:2776–2780.
1999.PubMed/NCBI
|
|
9
|
Dishop MK, Warner BW, Dehner LP, Kriss VM,
Greenwood MF, Geil JD and Moscow JA: Successful treatment of
inflammatory myofibroblastic tumor with malignant transformation by
surgical resection and chemotherapy. J Pediatr Hematol Oncol.
25:153–158. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Firat O, Ozturk S, Akalin T and Coker A:
Inflammatory myofibroblastic tumour. Can J Surg. 52:E60–E61.
2009.PubMed/NCBI
|
|
11
|
Tao YL, Wang ZJ, Han JG and Wei P:
Inflammatory myofibroblastic tumor successfully treated with
chemotherapy and nonsteroidals: A case report. World J
Gastroenterol. 18:7100–7103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Przkora R, Bolder U, Schwarz S, Jauch KW,
Spes J, Andreesen R and Mackensen A: Regression of nonresectable
inflammatory myofibroblastic tumours after treatment with
nonsteroidal anti-inflammatory drugs. Eur J Clin Invest.
34:320–321. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Berger A, Kim C, Hagstrom N and Ferrer F:
Successful preoperative treatment of pediatric bladder inflammatory
myofibroblastic tumor with anti-inflammatory therapy. Urology.
70(372): e13–e15. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Katayama R, Lovly CM and Shaw AT:
Therapeutic targeting of anaplastic lymphoma kinase in lung cancer:
A paradigm for precision cancer medicine. Clin Cancer Res.
21:2227–2235. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Butrynski JE, D'Adamo DR, Hornick JL, Dal
Cin P, Antonescu CR, Jhanwar SC, Ladanyi M, Capelletti M, Rodig SJ,
Ramaiya N, et al: Crizotinib in ALK-rearranged inflammatory
myofibroblastic tumor. N Engl J Med. 363:1727–1733. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
von Mehren M, Randall RL, Benjamin RS,
Boles S, Bui MM, Casper ES, Conrad EU III, DeLaney TF, Ganjoo KN,
George S, et al: Gastrointestinal stromal tumors, version 2.2014. J
Natl Compr Canc Netw. 12:853–862. 2014.PubMed/NCBI
|
